Skip to main content
    J

    Jasper Therapeutics Inc (JSPR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $11.77
    -1.91 (-13.96%)

    Market Cap: $15.18M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Jasper Therapeutics Inc (JSPR) Earnings: Report Dates and Results

    Updated Nov 16, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Jasper Therapeutics (JSPR) is expected to report earnings on Mar 29, 2027. In the quarter ended Sep 30, 2026, Jasper Therapeutics reported EPS of -$33.93, below the -$5.11 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    57%(12/21)
    Avg Surprise
    -28.42%

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$9.08
    Range-$13.52 - -$2.84
    7 analysts
    Revenue Consensus
    N/A
    RangeN/A
    6 analysts

    Next Report

    JSPR has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 21 quarters below that had an estimate, JSPR beat 12, missed 8 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 563.99% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$33.93-$5.11N/A-563.99%MissN/A11 up, 0 downNov 16, 2026
    Jun 30, 2026-$0.24-$0.37-$0.55 - -$0.33+35.14%BeatN/A21 up, 0 downAug 13, 2026
    Mar 31, 2026-$0.38-$0.54-$0.54 - -$0.54+29.63%BeatN/A11 up, 0 downMay 14, 2026
    Dec 31, 2025-$0.54-$0.82-$1.20 - -$0.52+33.82%BeatN/A50 up, 1 downMar 30, 2026
    Sep 30, 2025-$1.13-$1.21-$1.92 - -$0.75+6.61%BeatN/A61 up, 0 downNov 10, 2025
    Jun 30, 2025-$1.74-$1.33-$1.48 - -$0.76-30.83%MissN/A92 up, 1 downAug 13, 2025
    Mar 31, 2025-$1.41-$1.48-$1.80 - -$1.29+4.50%BeatN/A60 up, 4 downMay 12, 2025
    Dec 31, 2024-$1.62-$1.23-$1.36 - -$1.01-31.71%MissN/A70 up, 1 downFeb 27, 2025
    Sep 30, 2024-$1.24-$1.08-$1.15 - -$0.98-14.81%MissN/A90 up, 0 downNov 7, 2024
    Jun 30, 2024-$0.97-$1.12-$1.31 - -$0.94+13.39%BeatN/A90 up, 0 downAug 13, 2024
    Mar 31, 2024-$1.03-$1.23-$1.43 - -$1.10+16.26%BeatN/A60 up, 0 downMay 14, 2024
    Dec 31, 2023-$1.50-$1.57-$1.70 - -$1.50+4.46%BeatN/A40 up, 0 downMar 4, 2024
    Sep 30, 2023-$1.63-$1.50-$1.70 - -$1.40-8.67%MissN/A40 up, 0 downNov 9, 2023
    Jun 30, 2023-$1.51-$1.47-$2.00 - -$1.20-2.72%MissN/A50 up, 0 downAug 11, 2023
    Mar 31, 2023-$1.47-$1.50-$2.00 - -$1.30+2.00%BeatN/A50 up, 0 downMay 12, 2023
    Dec 31, 2022-$0.36-$0.36-$0.40 - -$0.340.00%In lineN/A41 up, 0 downMar 8, 2023
    Sep 30, 2022-$3.20-$3.70-$3.70 - -$3.20+13.51%BeatN/A40 up, 0 downNov 10, 2022
    Jun 30, 2022-$2.45-$3.60-$3.60 - -$2.30+31.94%BeatN/A30 up, 0 downAug 12, 2022
    Mar 31, 2022-$3.54-$3.40-$3.60 - -$3.40-4.12%Miss-904.5%20 up, 0 downMay 12, 2022
    Dec 31, 2021-$0.79-$0.34-$0.57 - -$0.24-132.35%MissN/A4N/AMar 18, 2022
    Sep 30, 2021-$2.67-$2.70-$3.90 - -$1.70+1.11%BeatN/A4N/ANov 12, 2021
    Jun 30, 2021-$1.31N/AN/AN/AN/AN/AN/AN/AAug 16, 2021
    Mar 31, 2021$0.44N/AN/AN/AN/A+300.0%N/AN/AMay 24, 2021
    Dec 31, 2020-$0.01N/AN/AN/AN/AN/AN/AN/AMar 30, 2021
    Sep 30, 2020-$0.02N/AN/AN/AN/AN/AN/AN/ANov 10, 2020
    Jun 30, 2020-$0.02N/AN/AN/AN/AN/AN/AN/AAug 13, 2020
    Mar 31, 2020$0.11N/AN/AN/AN/AN/AN/AN/AMay 13, 2020
    Dec 31, 2019Not reportedN/AN/AN/ANot reportedN/AN/AN/AMar 26, 2020
    Sep 30, 2019$0.00N/AN/AN/AN/AN/AN/AN/ANov 20, 2019
    Last 29 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$4.82, after -$4.86 the year before. It was $0.00 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$4.82N/A
    Dec 31, 2024-$4.86N/A
    Dec 31, 2023-$6.11N/A
    Dec 31, 2022-$9.55N/A
    Dec 31, 2021-$4.33-7316.7%
    Dec 31, 2020$0.06N/A
    Dec 31, 2019$0.00N/A

    Frequently Asked Questions About JSPR

    When is Jasper Therapeutics's next earnings date?

    Jasper Therapeutics's next earnings report is expected for Mar 29, 2027.

    Did JSPR beat earnings estimates last quarter?

    No. Jasper Therapeutics reported EPS of -$33.93 for the quarter ended Sep 30, 2026, below the -$5.11 estimate by 563.99%.

    What EPS do analysts expect from JSPR next quarter?

    The consensus EPS estimate for Jasper Therapeutics for the quarter ending Dec 31, 2026 is -$9.08 from 7 analysts, with estimates from -$13.52 to -$2.84.

    How often does JSPR beat earnings estimates?

    Jasper Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -64.60%.